Clueless Noob
liked
$Spectral AI(MDAI.US$ Spectral AI Calls On Authorities To Investigate The Likely Prevalence Of Naked Short Selling That Is Negatively Impacting Both MDAI Shares And Many Other De-SPAC Transaction Companies
4
Clueless Noob
liked
$Spectral AI(MDAI.US$ Spectral AI Announces Collaboration With Global Wound Care Company Polynovo to Introduce Deepview System for Burn Indication to Australian Market
2
Clueless Noob
liked
$Spectral AI(MDAI.US$ Spectral AI Expands Clinical Trial Sites for Pivotal U.S. Burn Study! Adds 2 new sites and expects to be concluded in Q4 24!
1
Clueless Noob
liked
$Crown Electrokinetics(CRKN.US$
Good Morning From Chicago USA 🇺🇸✌️
Good Morning From Chicago USA 🇺🇸✌️
5
Clueless Noob
liked
$Crown Electrokinetics(CRKN.US$ lfgggggg
3
1
Clueless Noob
liked
$Rigel Pharmaceuticals(RIGL.US$ Reuters · just Rigel Pharmaceuticals Completes Transfer of Gavreto® (Pralsetinib) New Drug Application! Will be available in from Rigel starting June 27
5
8
Clueless Noob
liked
$Spectral AI(MDAI.US$ Provided Support to Nasdaq and State Securities Authorities to Bring to Attention "Potential Market Manipulation" of Co's Common Stock
2
$Spectral AI(MDAI.US$ why keep going down?
1
3
Clueless Noob
liked
$Spectral AI(MDAI.US$
Spectral AI Reaches 50% Enrollment at Burn Centers for U.S. Pivotal Burn Study
Spectral AI (Nasdaq: MDAI) announced reaching 50% patient enrollment in its U.S. pivotal burn study, with 90 out of a target 240 patients enrolled. The study aims to validate the algorithm of the DeepView™ System, which utilizes AI for rapid and accurate assessment of burn wounds. Expected to complete enrollment by 2025, this trial represents the final step before seeking FDA approval. The D...
Spectral AI Reaches 50% Enrollment at Burn Centers for U.S. Pivotal Burn Study
Spectral AI (Nasdaq: MDAI) announced reaching 50% patient enrollment in its U.S. pivotal burn study, with 90 out of a target 240 patients enrolled. The study aims to validate the algorithm of the DeepView™ System, which utilizes AI for rapid and accurate assessment of burn wounds. Expected to complete enrollment by 2025, this trial represents the final step before seeking FDA approval. The D...
1